PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Division of Nephrology and Hypertension Center, Georgetown University, Washington, DC; and.\', \'Division of Cardiology, University of Michigan, Ann Arbor, MI.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1097/FJC.0000000000000960
?:doi
?:hasPublicationType
?:journal
  • Journal of cardiovascular pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33278189
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.917
?:rankingScore_hIndex
  • 89
is ?:relation_isRelatedTo_publication of
?:title
  • Is Spironolactone the Preferred Renin-Angiotensin-Aldosterone Inhibitor for Protection Against COVID-19?
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all